COMMUNIQUÉS West-GlobeNewswire

Precision Therapeutics’ Helomics Division Selected by AccuGenomics as Preferred Lab Partner for NIIMBL Grant
21/05/2019
MINNEAPOLIS, May 21, 2019 (GLOBE NEWSWIRE) -- Precision Therapeutics Inc., (Nasdaq: AIPT) (“Precision” or “the Company”), a company focused on applying artificial intelligence to personalized medicine and drug discovery [...]
Apotheca Biosciences’ (CBDC) Distribution of ProMED’s Pharma Grade CBD Products Receives Great Response -- Company in Discussion with Wholesalers for Mass Distribution of ProMED CBD Product Lines for an Initial 500 Outlets Nationally
21/05/2019
Saint Petersburg, FL, May 21, 2019 (GLOBE NEWSWIRE) -- via NEWMEDIAWIRE -- Apotheca Biosciences (OTC PINK: CBDC), a developer of cutting-edge medical & pharmaceutical products, nutraceuticals, and cannabis delivery [...]
Progressive Care Inc. Announces April Sales & Record Breaking Month
21/05/2019
MIAMI, May 21, 2019 (GLOBE NEWSWIRE) -- Progressive Care Inc. ( OTCQB: RXMD ), a personalized healthcare services and technology company, today announced further growth year-over-year in revenue and number of [...]
Quotient Ltd. Announces FDA Approval of Seven Additional Blood Bank Reagents
21/05/2019
JERSEY, Channel Islands, May 21, 2019 (GLOBE NEWSWIRE) -- Quotient Limited (NASDAQ: QTNT), an established, commercial-stage diagnostics company (the Company), today announced the U.S. Food and Drug Administration (FDA) [...]
Protech Home Medical Reports Solid Second Quarter Fiscal 2019 Financial Results
21/05/2019
Posts Revenue Growth of 17% and Adjusted EBITDA Growth of 78% NOT FOR DISSEMINATION IN THE UNITED STATES OR FOR DISTRIBUTION TO U.S. NEWSWIRE SERVICES AND DOES NOT CONSTITUTE AN OFFER OF THE SECURITIES DESCRIBED HEREIN [...]
Abeona Therapeutics Announces FDA Clearance of Investigational New Drug Application for ABO-202 Gene Therapy in CLN1 Disease
21/05/2019
NEW YORK and CLEVELAND, May 21, 2019 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO), a fully-integrated leader in gene and cell therapy, today announced that the Company is cleared to begin a Phase 1/2 [...]
PSIQ Reports Record Breaking Revenue Increase of Almost 120% for Its Hemp Derived CBD Product Line
21/05/2019
SUNRISE, Fla., May 21, 2019 (GLOBE NEWSWIRE) -- Profile Solutions, Inc. (OTC Pink: PSIQ) announced today that its wholly owned subsidiary, Elite Products International, Inc., reported revenues for the first quarter [...]
Jerome Zeldis, M.D., Ph.D, Former Chief Medical Officer of Celgene, to Join BioSig Board of Directors - Corrected Version
21/05/2019
Santa Monica, CA, May 21, 2019 (GLOBE NEWSWIRE) -- BioSig Technologies, Inc. (NASDAQ: BSGM), a medical device company developing a proprietary biomedical signal processing platform designed to address an unmet [...]
Transactions with shares and linked securities in H. Lundbeck A/S made by executives and their closely associated parties
21/05/2019
Valby, Denmark, 21 May 2019 – H. Lundbeck A/S (Lundbeck) hereby publishes and reports transactions made by executives and persons closely associated with them with shares and linked securities in Lundbeck. 1. Details of [...]
MediPharm Labs Announces Addition to $1.2B MJ ETFMG Alternative Harvest ETF (USA)
21/05/2019
TORONTO, May 21, 2019 (GLOBE NEWSWIRE) -- MediPharm Labs Corp. (TSXV: LABS) (OTCQX: MEDIF) (FSE:MLZ) (“MediPharm Labs”) a leader in specialized, research-driven cannabis extraction and cannabinoid isolation, is pleased [...]
Emerald Health Therapeutics tiendra une conférence téléphonique sur ses résultats financiers du premier trimestre 2019 le 31 mai prochain
21/05/2019
VANCOUVER, Colombie-Britannique, 21 mai 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc (« Emerald ») (TSXV : EMH ; OTCQX : EMHTF) tiendra sa conférence téléphonique sur les résultats financiers du premier [...]
Metacrine to Present at Jefferies 2019 Global Healthcare Conference
21/05/2019
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Metacrine, Inc., a clinical-stage biotechnology company focused on building an innovative pipeline of best-in-class drugs to treat liver and gastrointestinal (GI) diseases, [...]
Acasti Pharma to Present at the 20th Annual B. Riley FBR Institutional Investor Conference
21/05/2019
LAVAL, Québec, May 21, 2019 (GLOBE NEWSWIRE) -- Acasti Pharma Inc. (“Acasti” or the “Company”) (NASDAQ: ACST – TSX-V: ACST), a biopharmaceutical innovator focused on the research, development and commercialization of [...]
Crinetics Pharmaceuticals Initiates Phase 1 Study of CRN01941 for the Treatment of Neuroendocrine Tumors
21/05/2019
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Crinetics Pharmaceuticals, Inc. (Nasdaq: CRNX), a clinical stage pharmaceutical company focused on the discovery, development, and commercialization of novel therapeutics for [...]
Emerald Health Therapeutics to Hold Conference Call on First Quarter 2019 Financial Results on May 31st
21/05/2019
VANCOUVER, British Columbia, May 21, 2019 (GLOBE NEWSWIRE) -- Emerald Health Therapeutics, Inc.(“Emerald”) (TSXV: EMH; OTCQX: EMHTF) will host its first quarter 2019 financial results conference call on Friday, May 31 [...]
BioCryst’s Oral BCX7353 Meets Primary Endpoint in Phase 3 APeX-2 Trial
21/05/2019
NDA filing on-track for Q4 2019 RESEARCH TRIANGLE PARK, N.C., May 21, 2019 (GLOBE NEWSWIRE) -- BioCryst Pharmaceuticals, Inc. (Nasdaq: BCRX) today announced that the randomized (n=121), double-blind, placebo-controlled [...]
Axsome Therapeutics To Present Data From ASCEND Phase 2 Trial Of AXS-05 In Major Depressive Disorder At The 2019 American Society For Clinical Psychopharmacology Annual Meeting
21/05/2019
NEW YORK, May 21, 2019 (GLOBE NEWSWIRE) -- Axsome Therapeutics, Inc. (NASDAQ: AXSM), a clinical-stage biopharmaceutical company developing novel therapies for the management of central nervous system (CNS) disorders, [...]
Invivoscribe Expanding Clinical Laboratory Network Space and Testing Capabilities in San Diego, Germany, Japan, and China. Offering Comprehensive Standardized Testing for All Hematologic Malignancies
21/05/2019
SAN DIEGO, May 21, 2019 (GLOBE NEWSWIRE) -- Invivoscribe, Inc., a vertically integrated global company focused on Improving Lives with Precision Diagnostics ® , today announces expansion of space and testing [...]
Transactions in relation to share buyback program
21/05/2019
Acting under its share buyback authorization, the GN Store Nord Board of Directors initiated a share buyback program on May 1, 2019, in accordance with article 5 of Regulation (EU) no. 596/2014 of April 16, 2014 on [...]

Pages